Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,81 USD | -2,69% | -5,73% | +70,67% |
22/01 | Alaunos Therapeutics, Inc. Stelt Dale Curtis Hogue, Jr. aan als Interim Chief Executive Officer | CI |
02/01 | Alaunos Therapeutics, Inc. Benoemt Dale Curtis Hogue tot Bestuurder | CI |
Omzet 2023 * | 4K 3,71K | Omzet 2024 * | - | Marktkapitalisatie | 28,98 mln. 26,85 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | -35 mln. -32,42 mln. | Nettowinst (verlies) 2024 * | -9 mln. -8,34 mln. | EV/omzet 2023 * | 7.246 x |
Nettoliquiditeiten 2023 * | - 0 | Nettoliquiditeiten 2024 * | - 0 | EV/omzet 2024 * | - |
K/w-verhouding 2023 * |
-0,8
x | K/w-verhouding 2024 * |
-3,02
x | Werknemers | 34 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 95,6% |
Recentste transcriptie over Alaunos Therapeutics, Inc.
1 dag | -2,69% | ||
1 week | -5,73% | ||
Lopende maand | -13,40% | ||
1 maand | -22,98% | ||
3 maanden | +74,12% | ||
6 maanden | -8,03% | ||
Lopend jaar | +70,67% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dale Hogue
CEO | Chief Executive Officer | 54 | 29/12 |
Director of Finance/CFO | 62 | 17-02-21 | |
Chief Tech/Sci/R&D Officer | 44 | 04-08-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jaime Vieser
BRD | Director/Board Member | 54 | 16-12-20 |
Holger Weis
CHM | Chairman | 61 | 16-12-20 |
Robert Postma
BRD | Director/Board Member | 70 | 05-02-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.04% | 0 M€ | 0,00% | - | |
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 1,81 | -2,69% | 70 165 |
27-03-24 | 1,86 | -1,59% | 24 730 |
26-03-24 | 1,89 | -1,05% | 27 835 |
25-03-24 | 1,91 | +2,69% | 59 691 |
22-03-24 | 1,86 | -3,12% | 61 788 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+70,67% | 28,98 mln. | |
+2,73% | 108 mld. | |
+9,59% | 103 mld. | |
+6,58% | 23,48 mld. | |
-12,59% | 21,93 mld. | |
-3,29% | 19,68 mld. | |
-36,53% | 18,37 mld. | |
-13,29% | 16,33 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,15 mld. |